Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.50 HKD
Change Today -0.54 / -4.14%
Volume 830.0K
963 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

bloomage biotechnology (963) Snapshot

Open
$12.02
Previous Close
$13.04
Day High
$12.90
Day Low
$11.66
52 Week High
04/9/15 - $20.95
52 Week Low
12/17/14 - $9.73
Market Cap
4.2B
Average Volume 10 Days
517.5K
EPS TTM
$0.49
Shares Outstanding
333.6M
EX-Date
06/23/15
P/E TM
20.5x
Dividend
$0.03
Dividend Yield
0.20%
Current Stock Chart for BLOOMAGE BIOTECHNOLOGY (963)

Related News

No related news articles were found.

bloomage biotechnology (963) Related Businessweek News

No Related Businessweek News Found

bloomage biotechnology (963) Details

Bloomage BioTechnology Corporation Limited, an investment holding company, develops, manufactures, and sells bio-chemical products. It produces and sells hyaluronic acid (HA) raw materials used in pharmaceutical, cosmetic, and healthcare products. The company’s HA end products comprise hyaluronan soft tissue filling gel and medical sodium hyaluronate gel for ophthalmologic use, as well as bone products for intra-articular injection. It also develops, distributes, and sells medical devices, as well as sells beauty products. Bloomage BioTechnology Corporation Limited sells its products primarily in the People’s Republic of China, Asia, and the Americas. The company was founded in 2003 and is based in Jinan, the People’s Republic of China.

568 Employees
Last Reported Date: 04/16/15
Founded in 2003

bloomage biotechnology (963) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: CNY3.8M
Executive Director and Member of Nomination C...
Total Annual Compensation: CNY751.0K
Executive Director
Total Annual Compensation: CNY438.0K
Compensation as of Fiscal Year 2014.

bloomage biotechnology (963) Key Developments

Bloomage BioTechnology Corporation Limited Presents at Credit Suisse Asia Healthcare C-Level Conference, May-21-2015

Bloomage BioTechnology Corporation Limited Presents at Credit Suisse Asia Healthcare C-Level Conference, May-21-2015 . Venue: Credit Suisse Office, Level 88, International Commerce Center, 1 Austin Road West, Kowloon, Hong Kong.

Bloomage Biotechnology Corporation Limited Proposes Final Dividend for the Year Ended December 31, 2014

Bloomage BioTechnology Corporation Limited announced that at its AGM to be held on June 18, 2015, proposed final dividend of 2.5 Hong Kong cents per share for the year ended December 31, 2014.

Bloomage BioTechnology Corporation Limited, Annual General Meeting, Jun 18, 2015

Bloomage BioTechnology Corporation Limited, Annual General Meeting, Jun 18, 2015., at 15:00 China Standard Time. Location: Victoria IV, Level 2. Agenda: To receive and consider the audited consolidated accounts and reports of the directors and auditors of the company and its subsidiaries for the year ended December 31, 2014; to declare a final dividend of 2.5 cents per share for the year ended 31 December 2014; to consider the re-appointment of KPMG as auditors of the company and to authorize the board of directors of the company; to consider the re-election of executive directors and independent non-executive director; to grant a general mandate to the directors of the company to allot, issue and deal with additional shares; to grant a general mandate to the directors of the company to repurchase shares; and to extend the general mandate granted to the directors of the company to allot, issue and deal with additional shares in the share capital of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
963:HK $12.50 HKD -0.54

963 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 963.
View Industry Companies
 

Industry Analysis

963

Industry Average

Valuation 963 Industry Range
Price/Earnings 21.1x
Price/Sales 6.9x
Price/Book 4.4x
Price/Cash Flow 20.6x
TEV/Sales 6.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BLOOMAGE BIOTECHNOLOGY, please visit www.bloomagebio-tech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.